Santero Therapeutics
Santero Therapeutics is a novel antibiotics to combat antimocrobial resistante founded in 2021.
1
Funding Rounds
$8.6m
Money raised
Overview
Santero Therapeutics is a novel antibiotics to combat antimocrobial resistante founded in 2021.
- Website:
- Headquarters: Brussels
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Santero Therapeutics has raised a total of $8.6m in funding over 1 rounds.
Key Insights:
- Santero Therapeutics June 2023 Series A Funding Round: $8.6m
Santero Therapeutics June 2023 Series A Funding Round
$8.6m